Alberto Catanese

Albert Einstein Allee 11
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Correction: A rare missense variant impacting NEK1 kinase function is associated with ALS.

Correction: A rare missense variant impacting NEK1 kinase function is associated with ALS.

Journal: Acta neuropathologica communications

Published: July 21, 2026

Multiplex Panel Detects Glial and Inflammatory Biomarker Signatures in Sporadic and C9orf72-ALS.

Multiplex Panel Detects Glial and Inflammatory Biomarker Signatures in Sporadic and C9orf72-ALS.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 16, 2026

A rare missense variant impacting NEK1 kinase function is associated with ALS.

A rare missense variant impacting NEK1 kinase function is associated with ALS.

Journal: Acta neuropathologica communications

Published: February 25, 2026

Synaptic and cytoskeletal CSF signatures of motor neuron disease: the role of cyclase-associated protein 2.

Synaptic and cytoskeletal CSF signatures of motor neuron disease: the role of cyclase-associated protein 2.

Journal: Scientific reports

Published: October 23, 2025

Reply to "Extending the Interpretation of Biomarker Dynamics in SOD1-ALS Proteomics".

Reply to "Extending the Interpretation of Biomarker Dynamics in SOD1-ALS Proteomics".

Journal: Annals of neurology

Published: October 13, 2025

SYT13: An underestimated synaptotagmin.

SYT13: An underestimated synaptotagmin.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: March 28, 2025

RIG-I Mediated Neuron-Specific IFN Type 1 Signaling in FUS-ALS Induces Neurodegeneration and Offers New Biomarker-Driven Individualized Treatment Options for (FUS-)ALS.

RIG-I Mediated Neuron-Specific IFN Type 1 Signaling in FUS-ALS Induces Neurodegeneration and Offers New Biomarker-Driven Individualized Treatment Options for (FUS-)ALS.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 18, 2024

Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis.

Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis.

Journal: Annals of neurology

Published: December 16, 2024

Activation of polo-like kinase 1 correlates with selective motor neuron vulnerability in familial ALS.

Activation of polo-like kinase 1 correlates with selective motor neuron vulnerability in familial ALS.

Journal: Cell reports

Published: November 18, 2024

Inborn errors of canonical autophagy in neurodegenerative diseases.

Inborn errors of canonical autophagy in neurodegenerative diseases.

Journal: Human molecular genetics

Published: October 25, 2024

TBK1 is involved in programmed cell death and ALS-related pathways in novel zebrafish models.

TBK1 is involved in programmed cell death and ALS-related pathways in novel zebrafish models.

Journal: Cell death discovery

Published: September 23, 2024

ALS Mutations Shift the Isoelectric Point of the KIF5A C Terminal Inducing Protein Aggregation and TDP-43 Mislocalization.

ALS Mutations Shift the Isoelectric Point of the KIF5A C Terminal Inducing Protein Aggregation and TDP-43 Mislocalization.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: September 02, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026